ArticleFrontiers in endocrinology2022

Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.

Yihong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.